Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Kidney Neoplasms × olaparib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Ovarian Neoplasms 32 Breast Neoplasms 23 Triple Negative Breast Neoplasms 16 Prostatic Neoplasms 15 Fallopian Tube Neoplasms 11 Neoplasms 8 Pancreatic Neoplasms 6 Glioma 6 Endometrial Neoplasms 6 Carcinoma, Ovarian Epithelial 6 Stomach Neoplasms 5 Small Cell Lung Carcinoma 5 Sarcoma 5 Fanconi Anemia, Complementation Group D1 5 Cholangiocarcinoma 5 Urinary Bladder Neoplasms 4 Lymphoma, Non-Hodgkin 4 Carcinoma, Non-Small-Cell Lung 4 Advanced Breast Cancer 4 Uterine Cervical Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Recurrence 3 Osteosarcoma 3 Neoplasm Metastasis 3 Medulloblastoma 3 Lung Neoplasms 3 Glioblastoma 3 Colorectal Neoplasms 3 Wilms Tumor 2 Uveal Melanoma 2

Interventions

aldesleukin 19 Sunitinib 18 Bevacizumab 14 Interferon-alpha 13 Gemcitabine 13 Cyclophosphamide 13 Interleukin-2 12 fludarabine phosphate 11 Everolimus 11 Peripheral Blood Stem Cell Transplantation 9 Sorafenib 8 Axitinib 8 Nivolumab 7 pembrolizumab 6 Ipilimumab 6 Filgrastim 6 Doxorubicin 6 sargramostim 5 Carboplatin 5 Capecitabine 5 cabozantinib 4 Thalidomide 4 Tacrolimus 4 Radiotherapy 4 Radiosurgery 4 Mycophenolic Acid 4 Magnetic Resonance Spectroscopy 4 Erlotinib Hydrochloride 4 Bortezomib 4 temsirolimus 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03786796 2025-03-13

ORCHID

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡